Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

Ozempic, along with its sister drug Wegovy, belongs to a new class of ... with combinations of letters and numbers printed on the packaging, which are then used to track the product in a given ...

The 1.4 million square-foot facility, which is being constructed on land once belonging to a former Air Force base, is the ...

Earlier this month, two sources told Reuters that Novo Nordisk A/S’ (NYSE:NVO) is trying to move up the launch of Wegovy in India to better compete with Lilly. Lakdawala also said Eli Lilly will ...

Small compounders have until April 22 to stop making and selling versions of Novo Nordisk’s Wegovy; large compounders have until May 22. It is not clear how the F.D.A. will enforce these deadlines.

Meanwhile, US-listed shares of the Danish company Novo Nordisk, which markets both Ozempic and the higher-dose weight-loss variant Wegovy, slipped 3.9% amid concerns that a viable oral competitor ...

Five GLP-1RAs are available in the UK-dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide, which is the active ingredient in Ozempic and Wegovy. Ozempic is not marketed as a weight ...

Ohio Attorney General Dave Yost issued a warning to several Ohio medical spas over their alleged claims regarding weight-loss drugs.